Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid LeukemiaJohn C. Byrd, Peter Hillmen, Jennifer R. Brown et al.|New England Journal of Medicine|2014Cited by 1.6k
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphomaWyndham H. Wilson, Louis M. Staudt, Arthur L. Shaffer et al.|Nature Medicine|2015Cited by 1.1k
Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL studyFranck Morschhauser, Loretta J. Nastoupil, Saurabh Dahiya et al.|Nature Medicine|2024Cited by 127
Gene Expression Profile of Serial Samples of Transformed B-Cell LymphomasSven de Vos, Jonathan W. Said|Laboratory Investigation|2003Cited by 118